BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286,363 | -13.4% | 11,907 | +15.0% | 0.00% | 0.0% |
| Q2 2023 | $330,731 | +5.2% | 10,358 | +0.8% | 0.00% | -50.0% |
| Q1 2023 | $314,529 | -15.5% | 10,272 | +7.9% | 0.00% | 0.0% |
| Q4 2022 | $372,405 | -18.5% | 9,522 | -0.8% | 0.00% | -33.3% |
| Q3 2022 | $457,000 | +10.9% | 9,601 | -9.8% | 0.00% | +50.0% |
| Q2 2022 | $412,000 | -25.1% | 10,639 | +10.9% | 0.00% | -33.3% |
| Q1 2022 | $550,000 | -25.1% | 9,596 | +4.1% | 0.00% | -25.0% |
| Q4 2021 | $734,000 | +7.3% | 9,216 | +17.2% | 0.00% | 0.0% |
| Q3 2021 | $684,000 | -26.5% | 7,863 | +8.7% | 0.00% | -20.0% |
| Q2 2021 | $931,000 | +104.6% | 7,233 | +27.3% | 0.01% | +66.7% |
| Q1 2021 | $455,000 | +158.5% | 5,681 | +163.3% | 0.00% | +200.0% |
| Q4 2020 | $176,000 | – | 2,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |